InsiderTrades

Form 4 for LITE Lumentum

Accepted 2026-08-27 21:56:26 ET · period of report 2026-08-25 · accession 0001570465-26-000007 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MT 2026-08-27 21:56 2026-08-25 LITE Kim Jae SVP, GC S - Sale $852.58 -12.0K 37.8K -24% -$10.23M
T 2026-08-27 21:56 2026-08-25 LITE Kim Jae SVP, GC A - Grant $0.00 +1,635 39.4K +4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-25 S D 205 $842.39 49,599 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F2) These sales were executed in multiple trades at prices ranging from $842.06 to $843.02. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price, within the ranges set forth in footnotes (2) through (17) to this Form 4, upon request, to the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer.
2 Common Common Stock 2026-08-25 S D 280 $843.68 49,319 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F3) These sales were executed in multiple trades at prices ranging from $843.13 to $843.94.
3 Common Common Stock 2026-08-25 S D 360 $844.66 48,959 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F4) These sales were executed in multiple trades at prices ranging from $844.20 to $845.00.
4 Common Common Stock 2026-08-25 S D 570 $845.96 48,389 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F5) These sales were executed in multiple trades at prices ranging from $845.41 to $846.33.
5 Common Common Stock 2026-08-25 S D 456 $847.00 47,933 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F6) These sales were executed in multiple trades at prices ranging from $846.475 to $847.44.
6 Common Common Stock 2026-08-25 S D 491 $847.94 47,442 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F7) These sales were executed in multiple trades at prices ranging from $847.505 to $848.495.
7 Common Common Stock 2026-08-25 S D 600 $849.14 46,842 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F8) These sales were executed in multiple trades at prices ranging from $848.51 to $849.495.
8 Common Common Stock 2026-08-25 S D 600 $850.44 46,242 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F9) These sales were executed in multiple trades at prices ranging from $849.88 to $850.87.
9 Common Common Stock 2026-08-25 S D 970 $851.31 45,272 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F10) These sales were executed in multiple trades at prices ranging from $850.915 to $851.61.
10 Common Common Stock 2026-08-25 S D 1,998 $852.33 43,274 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F11) These sales were executed in multiple trades at prices ranging from $851.935 to $852.87.
11 Common Common Stock 2026-08-25 S D 851 $853.54 42,423 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F12) These sales were executed in multiple trades at prices ranging from $853.035 to $854.00.
12 Common Common Stock 2026-08-25 S D 1,080 $854.84 41,343 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F13) These sales were executed in multiple trades at prices ranging from $854.17 to $855.155.
13 Common Common Stock 2026-08-25 S D 273 $855.89 41,070 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F14) These sales were executed in multiple trades at prices ranging from $855.17 to $856.15.
14 Common Common Stock 2026-08-25 S D 1,679 $856.70 39,391 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F15) These sales were executed in multiple trades at prices ranging from $856.22 to $857.21.
15 Common Common Stock 2026-08-25 S D 815 $857.96 38,576 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F16) These sales were executed in multiple trades at prices ranging from $857.365 to $858.255.
16 Common Common Stock 2026-08-25 S D 40 $858.64 38,536 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026.
17 Common Common Stock 2026-08-25 S D 732 $860.04 37,804 D — — (F1) These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2026. (F17) These sales were executed in multiple trades at prices ranging from $859.99 to $860.69.
18 Common Common Stock 2026-08-25 A A 1,635 $0.00 39,439 D — — (F18) These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2025 Equity Incentive Plan.